⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RCKT News
Rocket Pharmaceuticals, Inc. Common Stock
Form 8-K
sec.gov
RCKT
RCKTW
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
businesswire.com
RCKT
Chronic Granulomatous Disease (CGD) Market Analysis and Outlook Report 2026-2036 - Emerging Gene Therapies, Lentiviral Vector-based Therapies and CRISPR-Cas9 Gene Editing, Ignite Hope
globenewswire.com
RCKT
First therapy funded by California taxpayer dollars is approved to treat rare childhood disorder
globenewswire.com
RCKT
Form 8-K
sec.gov
RCKTW
RCKT
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
businesswire.com
RCKT
Form 8-K
sec.gov
RCKT
RCKTW
Form 8-K
sec.gov
RCKTW
RCKT
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
businesswire.com
RCKT
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
businesswire.com
RCKT